Latest News

Preliminary clinical study results show improvement in MS symptoms

Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis, may improve symptoms in patients with the disorder, according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Brain networks 'hyper-connected' in young adults who had depression

  • New treatment for Multiple Sclerosis being investigated

  • How does it feel to be old in different societies?

  • Bedsharing with baby may impair sleep quality

  • This is your brain's blood vessels on drugs

  • Intervention needed for survivors of childhood burns

  • How studying damage to prefrontal lobe has helped unlock the brain's mysteries

  • Breastfeeding study shows need for effective peer counseling programs

  • Socially-assistive robots help kids with autism learn by providing personalized prompts

  • After Great Recession, Americans are unhappy, worried, pessimistic, study finds

  •